Drug information for OPTIVAR
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
SOLUTION/DROPS; OPHTHALMIC
0.05%
Prescription
AT (Reference Drug)
AZELASTINE HYDROCHLORIDE
azelastine
MEDA PHARMS
21127
2008-07-09 Label
2008-07-08 Letter
2004-09-03 Letter
2004-05-04 Label
2004-05-04 Label
2004-05-04 Letter
2004-05-04 Letter
2002-05-22 Review
2000-05-22 Letter
2000-05-22 Label
Drug Adverse Effects information for OPTIVAR
Role code
Indications
Reaction
# Reports
C
ASTHMA
ANAPHYLACTIC REACTION
2
C
COMPUTERISED TOMOGRAM ABDOMEN
FLUSHING
1
C
COMPUTERISED TOMOGRAM ABDOMEN
NASAL CONGESTION
1
C
COMPUTERISED TOMOGRAM ABDOMEN
PRURITUS
1
C
COMPUTERISED TOMOGRAM ABDOMEN
URTICARIA
1
C
HYPOGLOBULINAEMIA
ORAL CANDIDIASIS
1
C
HYPOGLOBULINAEMIA
SINUSITIS
1
C
IMMUNODEFICIENCY
ORAL CANDIDIASIS
1
C
IMMUNODEFICIENCY
SINUSITIS
1
C
INFLAMMATORY BOWEL DISEASE
ABDOMINAL PAIN
4
C
POST PROCEDURAL COMPLICATION
FLUSHING
1
C
POST PROCEDURAL COMPLICATION
NASAL CONGESTION
1
C
POST PROCEDURAL COMPLICATION
PRURITUS
1
C
POST PROCEDURAL COMPLICATION
URTICARIA
1
C
PREMEDICATION
FLUSHING
3
C
PREMEDICATION
NASAL CONGESTION
3
C
PREMEDICATION
PRURITUS
3
C
PREMEDICATION
URTICARIA
3
C
PRODUCT USED FOR UNKNOWN INDICATION
ANAPHYLACTIC REACTION
18
C
PRODUCT USED FOR UNKNOWN INDICATION
HEPATIC ENZYME INCREASED
26
C
PRODUCT USED FOR UNKNOWN INDICATION
KIDNEY INFECTION
26
Ads by Google